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Abstract
Significance: Skin tissue damage is a major challenge and a burden on healthcare systems, from burns
and other trauma to diabetes and vascular disease. Although the biological complexities are relatively
well understood, appropriate repair mechanisms are scarce. Three-dimensional bioprinting is a layerbased approach to regenerative medicine, whereby cells and cell-based materials can be dispensed in
fine spatial arrangements to mimic native tissue. Recent Advances: Various bioprinting techniques have
been employed in wound repair-based skin tissue engineering, from laser-induced forward transfer to
extrusion-based methods, and with the investigation of the benefits and shortcomings of each, with
emphasis on biological compatibility and cell proliferation, migration, and vitality. Critical issues:
Development of appropriate biological inks and the vascularization of newly developed tissues remain a
challenge within the field of skin tissue engineering. Future Directions: Progress within bioprinting
requires close interactions between material scientists, tissue engineers, and clinicians.
Microvascularization, integration of multiple cell types, and skin appendages will be essential for creation
of complex skin tissue constructs.
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CRITICAL REVIEW

Three-Dimensional Printing and Cell Therapy
for Wound Repair
Sylvia van Kogelenberg,1,2 Zhilian Yue,1,* Jeremy N. Dinoro,1
Christopher S. Baker,3,4 and Gordon G. Wallace1,*
1
ARC Centre of Excellence for Electromaterials Science, Intelligent Polymer Research Institute, AIIM Facility,
University of Wollongong, Wollongong, Australia.
2
Department of Orthopaedics, University of Utrecht, Utrecht, The Netherlands.
3
Department of Dermatology, St Vincent’s Hospital Melbourne, Melbourne, Australia.
4
Department of Medicine (Dermatology), University of Melbourne, Melbourne, Australia.

Significance: Skin tissue damage is a major challenge and a burden on
healthcare systems, from burns and other trauma to diabetes and vascular
disease. Although the biological complexities are relatively well understood,
appropriate repair mechanisms are scarce. Three-dimensional bioprinting is
a layer-based approach to regenerative medicine, whereby cells and cell-based
materials can be dispensed in fine spatial arrangements to mimic native tissue.
Recent Advances: Various bioprinting techniques have been employed in
wound repair-based skin tissue engineering, from laser-induced forward
transfer to extrusion-based methods, and with the investigation of the benefits and shortcomings of each, with emphasis on biological compatibility and
cell proliferation, migration, and vitality.
Critical issues: Development of appropriate biological inks and the vascularization of newly developed tissues remain a challenge within the field of
skin tissue engineering.
Future Directions: Progress within bioprinting requires close interactions
between material scientists, tissue engineers, and clinicians. Microvascularization, integration of multiple cell types, and skin appendages will be essential for
creation of complex skin tissue constructs.

Zhilian Yue, PhD
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SCOPE AND SIGNIFICANCE
The application of tissue engineering has been beneficial in
improving wound treatment and
alleviating the skin donor problem.1
However, as the skin is a complex
structure containing pigmentation, vessels, hair follicles, and different cell types, integrated into
a dynamic structure with different
properties distributed throughout,
many challenges remain.2,3 Ideally,
tissue-engineered constructs mimic
both structural organization and
biological function in native tissue.4
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Bioprinting, an additive manufacturing technique used for combining
biological components and biomaterials in a structured manner, shows
promise in this imitation process due
to the improved three-dimensional
(3D) spatial control of the multiple
components that can be introduced
within a single construct.5 Therefore,
significant improvements in the development of tissue-engineered skin
grafts can be made with bioprinting.
In addition, a better understanding
of dermatological diseases can be achieved via a thorough understanding
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of the mechanisms involved in wound healing,
using the continuously developed skin constructs.6
The knowledge accrued can further expedite the
development of bioprinting platforms to deliver
skin constructs with optimal biological functions.
Further, it may provide economic advantages and
improve reproducibility of the constructs.5

TRANSLATIONAL RELEVANCE
In small wounds, the stratum basale of the epidermis is capable of regenerating the epidermis of
the skin. However, when the stratum basale is affected and the dermis is damaged, regeneration is
delayed and scarring will occur. Bioprinting techniques may contribute to skin tissue engineering, by creating precisely controlled spatial cell
arrangements within a construct, mimicking the
multiple layers found in native skin, and replacing
the regenerative elements of the skin. In this manner, damaged skin could be restored and the amount
of scar formation decreased. This is of particular
importance within chronic wounds, wounds beyond
the epidermis, and large area wounds, as the natural
regeneration process is restricted. By offering the
potential to better simulate the anatomical structure
of the skin in a controllable and reproducible manner, bioprinting represents an appealing approach
to improve the efficacy of cell therapy for treatment
in full-thickness and complex skin wounds.
CLINICAL RELEVANCE
A range of tissue-engineered skin grafts have
been developed, and some of them have been approved for clinical utilization. These include epidermal, dermal, and epidermal/dermal substitutes.
However, for most applications, tissue-engineered
skin has yet to supplant the current gold standard
of a split-thickness autograft. Approaches that enable effective skin wound repair and regeneration of
clinical relevance are required. Bioprinting provides
a reproducible method for mass production of biological and mechanical appropriate constructs with
a high spatial organization of cells. Clinically, the
introduction of cell-laden biofabricated constructs
may accelerate wound healing and reduce scarring
at sites of injury, thereby increasing quality of
life. The possibilities in increasing the control of
spatial integration of biomaterials and cells in the
3D printed skin constructs may improve on the regeneration process, possibly decreasing necessary
intervention, thereby increasing the efficiency of
cell therapy and decreasing the strain on the medical system. Further, the development of new skin
substitutes may also improve the manageability

for the clinician. Lastly, the creation of skin substitutes may provide a valuable insight into skin
diseases.6

DISCUSSION OF FINDINGS
AND RELEVANT LITERATURE
The skin provides a protective barrier with immunologic and sensorial functions. It prevents
the invasion of harmful substances and pathogens,
such as bacteria, and protects against loss of moisture and electrolytes.7–9 When damaged, a natural
regeneration process is initiated, which consists of
three distinct phases: the inflammatory, new tissue
formation, and tissue remodeling phases. However,
when the wound encompasses all skin layers and/or
regenerative elements, healing is delayed or inhibited. Consequently, inadequately vascularized
scar tissue can be formed.8,10 To enhance the healing process, dressings and (synthetic) skin grafts
have been applied to the damaged area. However,
current treatments are insufficient in extensive
burns, chronic wounds, and other wounds that involve the loss of large amounts of skin. Hence, there
is an overwhelming need for the development of new
skin replacement strategies.
To develop a skin substitute, it is important to
understand formation, mechanical properties, and
cellular composition of the skin.11 Healthy skin
consists of three main components: the epidermis,
dermis, and hypodermis (Fig. 1).12 The epidermis,
containing mainly keratinocytes, is primarily responsible for the barrier function of the skin, including the prevention of harmful pathogens from
entering the body. It is structured from the outer
layer to the inner layer of the stratum corneum,
stratum lucidum, stratum granulosum, stratum
spinosum, and the stratum basale. Underneath the
stratum basale the connecting layer can be found
between the epidermis and the dermis, known as
the basement membrane zone. The dermis consists
of fibroblasts and extracellular matrix (ECM) components (collagen and elastin), blood vessels, nerves,
and appendageal structures. It is composed of two
layers, the papillary dermis (the upper layer), which
is responsible for the prevention of sliding between
the epidermis and the dermis and the provision of
oxygen and nutrients to the epidermis, and the reticular dermis, which is mainly responsible for the
mechanical properties of the skin. The hypodermis
consists mostly of adipose tissue.13
Wound treatment
Traditional wound dressings, such as bandages
and gauze, are used regularly to provide protection against pathogens and other environmental
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Figure 1. Anatomy of the skin.12 Permission obtained from McGraw-Hill Education. To see this illustration in color, the reader is referred to the web version of
this article at www.liebertpub.com/wound

hazards to stimulate appropriate wound healing.
However, as they absorb fluid extrusions and adhere to the wound, and induce damage on removal,
application of dressings may lead to impairment of
proper healing.14 Modern wound dressings have,
thus, been developed to overcome the limitations by
promoting the healing process in a moist environment. Examples of modern dressings include hydrocolloids, alginate, and nonalginate dressings.15
Wound treatments have been adapted to incorporate bioactive molecules, such as growth factors and
antimicrobial molecules.
For treatment of large area skin loss, including
severe burns, wound dressings are not sufficient.
Thus, skin grafts, where a piece of healthy skin
from a donor area, either partial thickness (split
skin) or full thickness or containing only epidermis,
is harvested and applied to the wound, are often
required to accelerate wound coverage and healing.
For epithelial autografting, epidermal cultures of
a patient’s keratinocytes have been explored, to
form confluent cell sheets. This has proved timeconsuming and costly. An alternative approach has
been developed, where autologous cells are used

in suspension and applied directly to a wound
surface by using a spray-on technique. This method
shows increased applicability to clinical situations,
and offers the potential to facilitate one-stage
treatment for partial thickness burns, and fullthickness wounds when combined with a dermal
regeneration template.16,17
Currently, autografts are a preferred method as
they provide good adhesion and pain relief, with
minimal rejection of the graft. This method is inherently limited by the availability of donor sites
and also, it leads to further trauma, potentially
resulting in additional complications. Allografts
gained popularity owing to their higher availability. However, in most cases, they provide only temporary ‘‘biological dressings.’’ Concerns remain
especially regarding immunological rejection, disease transmission, sensitization of the recipient,
and ethical considerations. The limitations and
developments mentioned earlier have prompted
the advance of skin tissue engineering and synthetic skin grafts.10 For a comprehensive review
on wound treatments, the readers are referred to
Boateng et al.18
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Skin tissue engineering
A contemporary and evolving process involves
skin tissue engineering. These skin replacements
are generally designed to remain within the skin
and degrade over time to reduce damage induced
on removal. By combining scaffolds with cells and
biomolecules, attempts are made to replace the
skin with a biological and mechanically sufficient
replacement to restore tissue function. However,
the synthetic skin grafts are often difficult to handle, with poor adhesion to the wound bed, poor
vascularization, no promotion of regeneration of
full-thickness wounds, and high manufacturing
costs.14 One of the main causes of these complications is the relative simplicity of the current tissueengineered constructs.19 To restore the skin to its
natural healthy conditions, the tissue replacement
should closely resemble the skin layering and
composition. Due to the complexity of the skin, the
development of a functional replacement tissue
remains challenging. Generally speaking, to engineer skin substitutes, four key requirements must
be met: (1) Engineered skin must be able to provide a moist environment; to promote healing and
prevent attachment of the dressing to the surrounding tissues. (2) Engineered skin must be able
to enhance natural wound-healing responses. (3)
Replacement tissue must also be able to provide
adequate oxygen exchange with the surrounding
environment. (4) It must limit the infiltration of
potential harmful bacteria and pathogens.14,20
Other considerations in the engineering of skin
substitutes are patient safety, degradation time,
duration of cover, shelf life, cost, mechanical stability, adequate vascularization, and number of
stages for completion of treatment.21 Preferably, a
replacement has the structural composition and
mechanical properties that are similar to the ECM
of the skin.22 Tissue-engineered skin substitutes
currently applied are epidermal substitutes, dermal substitutes, and dermo-epidermal substitutes.23,24 Epidermal substitutes are often cultured
(split thickness) epithelial autografts that can be
used in extensive burns. However, they have the
same disadvantages as with most of the autografts:
high infection risk, high cost, limited collection
site.22 Examples of dermal substitutes used in a
clinical setting are Integra, AlloDerm, Dermagraft, and Matriderm. The application of Integra, AlloDerm, or Dermagraft involves a
two-step process.19 Integra, a crosslinked bovine
collagen-based matrix, has a good long-term aesthetic and functional outcome, but with high cost
and a poor adhesion to wound site. AlloDerm,
human acellular dermis in a lyophilized form,

provides a matrix closely resembling the patients’
skin delivering good vascularization and regeneration. This method is restrained by high costs, disease transmission between donors. Dermagraft,
a synthetic material made from bioabsorbable
polyglactin seeded with neonatal human foreskin
fibrolasts, improves ease of handling for the surgeon, shows no rejection, and can be applied on
chronic wounds; however, poor ECM structures,
infections, and cellulitis have been reported.
Matriderm, a noncrosslinked lyophilized bovine
material, is a one-stage process that promotes
vascularization and improves stability and elasticity of regenerated tissue.22 This material, currently
used for dermal grafts, has also been applied as an
ink material in biofabrication. Lastly, examples
of dermo-epidermografts are PermaDerm and
DenovoSkin, which more closely resemble the native skin, but no clinical trials have been reported
as of yet.23 For more comprehensive overviews of
current skin substitutes, refer to Hrabchak et al.,
Metcalfe and Ferguson, or Chua et al.3,19,23
Tissue-engineered skin can be enhanced by the
addition of growth factors and other biomolecules,
regulating several wound-healing-related processes, as the ECM has been an important factor
in growth factor regulation and delivery.25 Major
growth factors and cytokines that can be added to
modulate wound healing are epidermal growth
factor (EGF), basic fibroblast growth factor (bFGF),
transforming growth factor-b (TGF-b), plateletderived growth factor (PDGF), vascular endothelial
growth factor (VEGF), interleukin (IL)-1, IL-6, and
tumor necrosis factor-a (TNF-a). These influence reepithelialization, granulation tissue formation,
matrix formation and remodeling, and inflammation levels.26,27 When added unaided, proteases at
the wound site have shown to interfere with efficacy.
Therefore, combining growth factors with wound
dressings and/or tissue-engineered skin grafts improves healing by creating an appropriate wound
environment. To improve the therapeutic efficacy of
growth factors, a number of delivery strategies have
been developed to enable controlled spatial/temporal
presentation of growth factors at the site of injury.
These include, for example: lipid nanoparticle systems, ECM-inspired growth factor delivery systems,
and nanofibrous structures.27,28 Due to the limited
scope of this article, readers are referred to a couple
of excellent reviews by Gainza et al., Barrientos
et al., and Pachuau.26–28
Improvements in tissue-engineered skin substitute healing can be made in regards to the high
manufacturing costs, regeneration of the skin, immune rejection, ease of handling, and complexity of
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construct to closer resemble the anatomy of the skin.
High manufacturing costs may be addressed by the
use of bioprinting, which would reduce manual labor and also bring standardization to the fabrication
process to produce reproducible skin substitutes.
Bioprinting
Bioprinting is an emerging additive manufacturing tool in tissue engineering and regenerative
medicine. Using a computer-aided design, it provides an unprecedented ability to strategically assemble biomaterials and cells to build 3D structures.
Bioprinting provides an economically viable and
reproducible method for the creation of spatially
organized, biologically compatible, and mechanically stable constructs, mimicking the natural
organization of healthy skin. In addition, patientspecific wound dressings and skin substitutes
could be fabricated with embedded ECM components, growth factors, and cell types, precisely
tailored to each region and wound depth, facilitating the body’s natural response to trauma while
protecting the wound site.10
For bioprinting, core elements involve the type
of printer and bioink formulation, which act in
concert to determine the printing method and
process, and subsequently the biological and mechanical characteristics of the 3D printed construct.
Key modalities of printing that have been explored
for cell printing are inkjet printing, laser-induced
forward transfer (LIFT), and extrusion printing
(discussed in the next section). The materials used
to build the 3D construct are constituent of the
bioinks; these materials comprise synthetic and/or
naturally derived polymers, and they are employed
to facilitate cell printing and to provide extracellular
environments to support cell proliferation and/or
differentiation as required.

Figure 2. Schematic representation of an inkjet printer.

149

Bioprinting modalities and bioink
In inkjet printing, a cartridge is filled with a
bioink, which is dispensed in droplets onto the collector plate via thermal or acoustic forces (Fig. 2).4
For thermal printing, pressure pulses are created
by electrically heating the print head. Acoustic
printing applies an acoustic wave to eject droplets.29–31 The size of the droplets can be controlled
by regulating various parameters, such as temperature and viscosity of the bioink, and the amplitude
and frequency of the printing parameters.30
As with all bioprinting approaches, inkjet
printing has its advantages and limitations. Regarding thermal approaches, inks are exposed to
temperatures over 200C for short bursts, and so
the capacity of inks to recover from abrupt temperature change is critical. Interestingly, the impact on
encapsulated cells appears to be negligible.32,33
Another significant limitation relates to the mechanical stresses imposed on encapsulated cells,
with a considerably narrow viscosity tolerance
range.34 Moreover, frequent nozzle clogging and
inconsistent droplet formation impart further
difficulties. Therefore, bioinks used within this
technique should remain within a 3.5–12 mPa/s
viscosity range and low cell densities (typically
<106 cells/mL) are usually employed.35 Despite
these limitations, however, printing resolution
can be high, enabling precise positioning of cells.34
In addition, the availability of such printers is
vast, generally resulting in low maintenance and
service costs.
LIFT within the field of bioprinting is often referred to as LAB or LABP (Fig. 3).36 Unlike inkjet
printing, LIFT does not require a printing nozzle,
subjugating particular limitations in regards to
clogging of the nozzle. Figure 3 illustrates a simple
representation of the technology, where a donor
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Figure 3. A schematic representation of LIFT. LIFT, laser-induced forward transfer.

layer, containing an energy-absorbing layer commonly made of gold or titanium but also polymers
such as gelatine or triazine, is excited through laser pulses.37,38 These pulses penetrate and vaporize
the donor layer, creating a vapor bubble. The formed
hydrogel jet cascades onto the collector slide as a
fine resolution droplet with high spatial control.39
Droplet size can be regulated by laser energy, hydrogel depth, and viscosity.40 The ink viscosity
ranges for LIFT methods are not as narrow as inkjet
methods, 1–300 mPa/s compared with 3.5–12 mPa/s.
Correspondingly, nozzle, needle, and/or tip clogging
are not an issue.36
Arguably the most extensively explored bioprinting approach in tissue engineering so far involves
microextrusion.41–43 Instead of droplets, extrusion

Figure 4. A schematic representation of an extrusion printer.

bioprinting dispenses continuous cylindrical strands
of hydrogel by using air or mechanical force
(Fig. 4).44–46 The former system employs pneumatics to drive the filament through the tip, which
is restricted only by pressure and the delay of its
volume. Mechanical or robotic extrusion printers use either piston or screw mechanisms to
project hydrogels, with modest spatial control and
resolution.
Due to relative simplicity, ink properties for extrusion printing are less restricted compared with
other approaches, supporting a vast viscosity range
of 30 mPa/s to at least 6 · 107 mPa/s.30 The cell
density can also be increased significantly, therefore making it possible to achieve physiological
relevant cell densities. In addition to cell sus-
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pensions, cell pellets, tissue spheroids, and tissue
strands have also been successfully printed.46–49
A significant shortcoming of extrusion-based
bioprinting, apart from the resolution (hundreds
of microns), involves the shear stresses experienced by encapsulated cells during printing.
High viscosities result in enhanced shape fidelity
at the expense of high shear stress. Thus, to
achieve both high cell viability and shape fidelity,
a bioink should demonstrate shear-thinning behavior during printing and then rapid recovery
or cessation after extrusion.43 Ink viscosity determines printability and cell viability, which
are influenced by polymer concentration and
crosslinking. Coupled with these material properties are the hardware restrictions bestowed on
inks, ranging from, but not restricted to, pressure, flow rate, temperature, and substrate interactions.35,50
Skin printing
In recent years, skin printing has gained popularity in the field of skin tissue engineering. Several printing techniques have been applied in the
attempt of skin tissue formation. In 2009, Lee et al.
applied a stage-controlled inkjet printer to create
a layer-by-layer construct containing both primary
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adult human dermal fibroblasts and primary
adult human epidermal keratinocytes, which were
printed in a polydimethylsiloxane mold simulating
a nonplanar skin wound. The artificial skin was
constructed by printing layers of collagen, onto
which a layer of cells could be deposited. After each
layer, the cell-containing gel was crosslinked by
using nebulized NaHCO3 vapor. The design consisted of 10 layers of collagen, the second layer
seeded with fibroblasts, and the eighth layer containing keratinocytes (Fig. 5A). Viability after
printing was comparable to the control group for
both fibroblasts (>95%) and keratinocytes (>80%),
indicating minimal damage due to inkjet printing
and shear stresses. However, an inhomogeneous
organization of the printed cells was still present.13
An alternate method was described by Lee et al.,
where an alternate spatial organization of collagen
layers was applied. To approach the structure and
spatial cell organization of native skin, keratinocytes were printed with a high density in the two
upper layers, whereas a lower density of fibroblasts
was printed into three layers equally distributed
throughout the remaining construct (Fig. 5B).13
The 3D printed constructs were better able to retain
their shape after 7 days of culture, compared with
manual deposition.51 Potential of inkjet printing in

Figure 5. Construction of two designs of layer-by-layer printing of collagen, human dermal fibroblasts, and keratinocytes. (A) Illustrates the design containing
10 layers, with layer 2 consisting of collagen and embedded fibroblasts, and layer 8 containing keratinocytes. Obtained and modified from13 with permission
from Elsevier. (B) Illustrates the method containing 2 top layers containing keratinocytes and 3 layers of fibroblasts distributed equally in the bottom 11 layers.6
Obtained and modified from Lee et al.6 with permission from Mary Ann Liebert. To see this illustration in color, the reader is referred to the web version of this
article at www.liebertpub.com/wound
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skin tissue engineering has been shown by the
heightened control of cell density, organization, and
combining multiple cell types.
LIFT was applied in the development of 3D
spatially controlled constructs resembling human
skin and, in both instances, resulted in wellorganized tissue constructs. Koch et al. created a
bi-layered construct, containing murine fibroblasts
and human immortalized keratinocytes in Matriderm. Ten days of culture demonstrated proliferation
in all cells, which was used to verify the cell vitality. Also, a layer of laminin, the main component of
the basal lamina, had formed in between the keratinocyte and fibroblast layer. The formation of this
layer showed the increasing complexity that can
be formed by the 3D spatial arrangement of the
cells and the influence of multiple cell types in one
structure. The intra-cellular communication was
assessed by analysis of adherence and gap junctions. Adherence junctions were found in abundance between the keratinocytes, but to a lesser
extent between the fibroblasts.36 Similarly, Michael
et al. applied LIFT to fabricate a cellularized skin
substitute, assembling a construct containing 20
layers of keratinocytes on 20 layers of fibroblasts in
Matriderm. These constructs were tested in vivo in
full-thickness wounds in mice. All animals survived
the surgery and surrounding tissue connected with
the implanted skin substitute; no inflammatory or

necrotic processes were detected. Proliferation in
the epidermal and dermal layer was found in both
healthy mouse skin and the skin constructs, but not
in the negative control. In the skin substitute, a
blood vessel was formed after 11 days, but complete
vascularization was not achieved.52 Both studies
show LIFT as a promising technique in skin tissue
engineering, due to improved cellular spatial arrangement, angiogenesis stimulation, and integration with host tissues.
Recently, extrusion printing was applied for the
development of skin substitutes. Kim et al. applied
a combination of gelatin and agar with extrusion
printing to create skin substitutes for the treatment of laser tattoo removal.53 Multiple skin types
were emulated, with varying colors and light absorption, to accommodate multiple different skin
types. For all types, constructs were determined to
be of 138.5 – 0.1 lm and 0.81 – 0.04 mm thickness
for the epidermis and dermis, respectively, which is
relatively low, but within the range of native human skin.53 Cubo et al. printed a skin construct
with a dermal layer consisting of human dermal
fibroblasts, CaCl2, and human plasma.2 Interestingly, the authors applied a printing technique
whereby the ink is mixed during the printing process. Directly afterward, human keratinocytes were
printed over the initial construct. The constructs
were left in incubation overnight, after which the

Figure 6. The visual appearance of a bioprinted graft in an immunodeficient mouse is shown in (A), and (B) shows a typical haematoxylin and eosin (H/E)stained sample of the bioprinted human skin grafts in immunodeficient mice and (C) shows a typical H/E-stained sample of native human skin, with the white
line indicating the dermo-epidermal junction (scale bar: 100 lm). Obtained and modified from Cubo et al.2 with permission from IOP Publishing. To see this
illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/wound
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constructs were implanted in immunodefiTAKE-HOME MESSAGES
cient mice. The in vivo skin showed a
 Biofabrication holds promise in healing of large or chronic skin wounds.
structure similar to human skin, contrasting with the surrounding native mouse skin
 Biofabrication may be applied in healing of deep wounds, encompassing
(Fig. 6). Identified were the stratum basale,
several layers, and preventing scar formation in the dermal layer of the
stratum spinosum, stratum granulosum,
skin.
and stratum corneum, suggesting a normal
 Reproducibility may be increased with the application of biofabrication.
functioning epidermal layer. In addition,
 Biofabrication may hold promise in tissue engineering; however, further
neoangiogenesis formation was observed.2
developments in fabrication techniques and bioinks are a necessity.
Similarly, attempts have been made in
regard to the creation of an in situ biorelease, resulting in heightened vessel formation in
printing technique, where human dermal
mice compared with a fast release profile.57 More
fibroblasts and human keratinocytes have been
recently, growth factors have been incorporated into
loaded into a printer and printed directly on the
PLGA microparticles and printed in micrometer
dorsa of athymic mice, resulting in complete closcale resolutions.58 This type of microparticle-based
sure of the wound after 3 weeks.54
biomolecule inclusions could be customized and
Further optimization of bioprinting techniques
applicable for different types of tissue regeneration
and combination with other biofabrication techand can, therefore, also be explored in combination
niques may lead to more complex tissue constructs,
with wound healing, thereby increasing targeting
best mimicking the organization of the skin and the
10
precision, improving control of growth factor redifferent ECM components in each layer.
lease, and creating the possibility of individualizing
the process based on patient need.
FUTURE DIRECTIONS
Predominantly vascularization within the constructs remains an important challenge in skin tisBioprinting techniques show potential in exsue fabrication.3 The native dermis is a vascularized
panding current knowledge, in developing tissues
tissue and can range between 0.3 and 4 mm in
closer resembling native tissues, and in addresthickness depending on the location. The epidermis
sing current skin tissue engineering complications
depends on the vascularization within the dermis
such as skin type differences, vascularization, and
for its oxygen and nutrient exchange. Therefore, in
cell organization. During the printing process, the
thicker multiple-layered constructs, there is often
bioink formulation must be both stable and fluidic
necrosis of the epidermal layer. Significant adenough to be extruded. After extrusion, the material
vances in creating vascularized networks and 3D
must be such that the printed structure retains
printed structures will have to be made before the
shape and provides mechanical behavior similar to
development of large functional tissue constructs
the specific tissue. The most common approach to
can be realized. The introduction of several other
bioprinting involves cell encapsulation in a hydroskin components, such as hair follicles, sweat
gel, as the mechanical properties of the resulted
glands, and melanocytes, has yet to be realized.
structure and water retention properties of most
hydrogels closely resemble the ECM. Therefore,
other biomolecules, such as growth factors, can be
SUMMARY
added to the bioprinted constructs to influence epiBioprinting has been used to demonstrate the
thelialization, tissue formation, tissue remodeling,
potential to expedite skin tissue engineering. By
and inflammation. Examples of biomolecules incorcombining current knowledge on material science,
porated into hydrogels are VEGF in fibrin gels for
engineering, and cell biology, this interdisciplinneural stem culture and the bioprinting of fibroblast
ary approach can be applied to address current
growth factor-2 and bone morphogenetic protein-2
limitations, especially in vascularization and skin
onto sub-micron fibrous scaffolds to increase spatial
appendages, increasing reproducibility, and incontrol of cells. Besides, the printing of growth faccreasing patient specificity. However, progression
tors onto a hydrogel in specific patterns can also
can only be made through close collaboration beinfluence cell organization.54–56 Incorporation of
tween clinicians and researchers.
growth factors within micro particles, which are
combined with a bioink, improves release control.
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3D
ECM
IL
LAB/LABP
LIFT
VEGF

¼
¼
¼
¼
¼
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three-dimensional
extracellular matrix
interleukin
laser-assisted bioprinting
Laser-induced forward transfer
vascular endothelial growth factor

